198 related articles for article (PubMed ID: 25613965)
21. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
[TBL] [Abstract][Full Text] [Related]
22. Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress.
Clemens J; Holmgren J; Kaufmann SH; Mantovani A
Nat Immunol; 2010 Dec; 11(12):1069-72. PubMed ID: 21079627
[TBL] [Abstract][Full Text] [Related]
23. Challenges to sustainable immunization systems in Gavi transitioning countries.
Cernuschi T; Gaglione S; Bozzani F
Vaccine; 2018 Oct; 36(45):6858-6866. PubMed ID: 30268735
[TBL] [Abstract][Full Text] [Related]
24. Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).
Gandhi G
BMC Public Health; 2015 Nov; 15():1198. PubMed ID: 26621528
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Conflict on Immunisation Coverage in 16 Countries.
Grundy J; Biggs BA
Int J Health Policy Manag; 2019 Apr; 8(4):211-221. PubMed ID: 31050966
[TBL] [Abstract][Full Text] [Related]
26. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
[TBL] [Abstract][Full Text] [Related]
27. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
[TBL] [Abstract][Full Text] [Related]
28. Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Apr; 62(16):308-11. PubMed ID: 23615674
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.
Jit M; Brisson M; Portnoy A; Hutubessy R
Lancet Glob Health; 2014 Jul; 2(7):e406-14. PubMed ID: 25103394
[TBL] [Abstract][Full Text] [Related]
30. The Global Alliance for Vaccines and Immunization: is it a new model for effective public-private cooperation in international public health?
Muraskin W
Am J Public Health; 2004 Nov; 94(11):1922-5. PubMed ID: 15514228
[TBL] [Abstract][Full Text] [Related]
31. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
Brenzel L
Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
[TBL] [Abstract][Full Text] [Related]
32. Global invasive bacterial vaccine-preventable diseases surveillance--2008-2014.
Murray J; Agócs M; Serhan F; Singh S; Deloria-Knoll M; O'Brien K; Mwenda JM; Mihigo R; Oliveira L; Teleb N; Ahmed H; Wasley A; Videbaek D; Wijesinghe P; Thapa AB; Fox K; Paladin FJ; Hajjeh R; Schwartz S; Van Beneden C; Hyde T; Broome C; Cherian T;
MMWR Morb Mortal Wkly Rep; 2014 Dec; 63(49):1159-62. PubMed ID: 25503919
[TBL] [Abstract][Full Text] [Related]
33. Ensuring childhood vaccination among slums dwellers under the National Immunization Program in India - Challenges and opportunities.
Singh S; Sahu D; Agrawal A; Vashi MD
Prev Med; 2018 Jul; 112():54-60. PubMed ID: 29626558
[TBL] [Abstract][Full Text] [Related]
34. The GAVI Financing Task Force: one model of partner collaboration.
Milstien JB; Kamara L; Lydon P; Mitchell V; Landry S
Vaccine; 2008 Dec; 26(51):6699-705. PubMed ID: 19306508
[TBL] [Abstract][Full Text] [Related]
35. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
[TBL] [Abstract][Full Text] [Related]
36. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage.
Lim SS; Stein DB; Charrow A; Murray CJ
Lancet; 2008 Dec; 372(9655):2031-46. PubMed ID: 19070738
[TBL] [Abstract][Full Text] [Related]
37. Perceptions of the usefulness of external support to immunization coverage in Chad: an analysis of the GAVI-Alliance cash-based support.
Ferrinho P; Dramé M; Tumusiime P
Pan Afr Med J; 2013; 15():44. PubMed ID: 24106572
[TBL] [Abstract][Full Text] [Related]
38. Global routine vaccination coverage, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(44):1520-2. PubMed ID: 22071590
[TBL] [Abstract][Full Text] [Related]
39. GAVI and the Vaccine Fund--a boon for immunization in the developing world.
Balaji KA
Indian J Public Health; 2004; 48(2):45-8. PubMed ID: 15709583
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
